Home Business Drugmaker Novo Nordisk slashes Wegovy sales forecasts, blaming compounding

Drugmaker Novo Nordisk slashes Wegovy sales forecasts, blaming compounding

by admin

Novo Nordisk lowered its sales forecast for obesity drug Wegovy, citing competition from compounded versions.

Compounding pharmacies are crimping sales of Novo Nordisk's obesity drug Wegovy by making what are essentially copies of the name-brand medicine. The company says it trying to stop them.

(Image credit: Scott Olson)

Original Article

You may also like

Leave a Comment

one × 4 =